Paper77050
Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N and 2 others. Thromb Haemost, 1978. Cited by 86 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. Papers, record 77050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77050
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifibrinolytic Agents | Major topic |
| Fibrinolysis | Major topic |
| Aminocaproic Acid | |
| Humans | |
| Plasminogen | |
| Urokinase-Type Plasminogen Activator | |
| alpha-Macroglobulins |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,452,200 | Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target. | TH Open | 2022 | https://conductscience.org/library/papers/36452200 | PubMed |
| 31,249,945 | Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review. | TH Open | 2018 | https://conductscience.org/library/papers/31249945 | PubMed |
| 23,118,509 | Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. | J Biomed Biotechnol | 2012 | https://conductscience.org/library/papers/23118509 | PubMed |
| 18,564,219 | Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. | J Thromb Haemost | 2008 | https://conductscience.org/library/papers/18564219 | PubMed |
| 7,199,538 | Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199538 | PubMed |
| 6,459,779 | Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin. | Biochem J | 1981 | https://conductscience.org/library/papers/6459779 | PubMed |
| 6,444,305 | Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6444305 | PubMed |
| 6,178,757 | Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6178757 | PubMed |
| 6,166,634 | Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6166634 | PubMed |
| 3,166,140 | Organization of the human alpha 2-plasmin inhibitor gene. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3166140 | PubMed |
| 3,100,038 | Streptokinase, urokinase, and tissue plasminogen activator: pharmacokinetics, relative advantages, and methods for maximizing rates and consistency of lysis. | Cardiovasc Intervent Radiol | 1986 | https://conductscience.org/library/papers/3100038 | PubMed |
| 3,088,041 | Localization of the binding site of tissue-type plasminogen activator to fibrin. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3088041 | PubMed |
| 2,526,671 | Clinical disorders of fibrinolysis: a critical review. | Blut | 1989 | https://conductscience.org/library/papers/2526671 | PubMed |
| 1,708,234 | Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin. | Biochem J | 1991 | https://conductscience.org/library/papers/1708234 | PubMed |
| 156,364 | Inhibitory spectrum of alpha 2-plasmin inhibitor. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/156364 | PubMed |
| 156,196 | Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. | J Clin Invest | 1979 | https://conductscience.org/library/papers/156196 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| A2M | 2 | PubTator's text mining | https://conductscience.org/library/genes/2 | NCBI Gene |
| PLAU | 5,328 | PubTator's text mining | https://conductscience.org/library/genes/5328 | NCBI Gene |
| PLG | 5,340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINF2 | 5,345 | PubTator's text mining | https://conductscience.org/library/genes/5345 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/77050
GET https://conductscience.org/api/papers/v1/77050/authors